← Open Payments lookup

SYDNEY TANG: Open Payments

NPI 1508592759 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,564 in 151 payments from 16 companies in 2025. Trend: 2023 $835 · 2024 $2,067 · 2025 $3,564

Food & beverage: $3,488Education: $76
CompanyPaymentsAmount
GENZYME CORPORATION18$537
Janssen Biotech, Inc.29$521
Incyte Corporation21$438
Galderma Laboratories, L.P.13$326
ABBVIE INC.16$306
Organon LLC6$302
Regeneron Healthcare Solutions, Inc.8$244
Arcutis Biotherapeutics, Inc.10$234
Amgen Inc.13$226
Novartis Pharmaceuticals Corporation5$166

Products named: DUPIXENT, TREMFYA, OPZELURA, NEMLUVIO, VTAMA, SKYRIZI, Zoryve, Otezla.

Industry payments across CA — which companies pay providers there.